HCID 136344431, compound → HCID 86705044, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([N:18]2[C:26]3[C:21](=[C:22]([NH:27][S:28]([CH3:31])(=[O:30])=[O:29])[CH:23]=[CH:24][CH:25]=3)[CH:20]=[CH:19]2)([CH2:16][CH3:17])[C:9]([NH:11][C:12](=[N:14]O)[CH3:13])=[O:10])=[CH:4][CH:3]=1>C1COCC1>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([N:18]2[C:26]3[C:21](=[C:22]([NH:27][S:28]([CH3:31])(=[O:29])=[O:30])[CH:23]=[CH:24][CH:25]=3)[CH:20]=[CH:19]2)([C:9]2[O:10][N:14]=[C:12]([CH3:13])[N:11]=2)[CH2:16][CH3:17])=[CH:4][CH:3]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 2-(4-chlorophenyl)-N-(1-(hydroxyimino)ethyl)-2-(4-(methylsulfonamido)-1H-indol-1-yl)butanamide (148 mg, 0.32 mmol) in THF (5 mL) was heated at 70° C. for 2 days. Then the solvent was removed in vacuo to afford the crude product. The product was purified by column chromatography (50% EtOAc/hexanes), then by chiral separation following the conditions below provided the title compound as a single enantiomer.
Workup
- customThen the solvent was removed in vacuo
- customto afford the crude product
- customThe product was purified by column chromatography (50% EtOAc/hexanes)
- customby chiral separation
Sources & evidence
- ORD record
- ord-7b9e6a4220764e44aad18949198fc9c8
- Source dataset
- uspto-grants-2015_01
- Patent number
- US08933113B2
Reaction notes
Loading…